US 12029735
Polymorphic compounds and uses thereof
granted A61KA61K31/47A61K45/06
Quick answer
US patent 12029735 (Polymorphic compounds and uses thereof) held by Aldeyra Therapeutics, Inc. expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aldeyra Therapeutics, Inc.
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/47, A61K45/06, A61P, A61P1/00